Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases;Neumonía comunitaria por Legionella pneumophila serogrupo 1. Estudio de 97 casos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 8, 2003, Pages 394-400

  Benito, José Ramón ^a   Montejo, José Miguel ^a   Cancelo, Laura ^a   Zalacaín, Rafael ^a   López, Leyre ^a   Gil de Pareja, Joaquín Fernández ^a   Alonso, Eva ^b   Oñate, Javier ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b U de Vigilancia Epidemiologica   (Spain)

Author keywords

Clarithromycin; Community acquired infections; Erythromycin; Legionella pneumophila; Pneumonia; Rhabdomyolysis; Rifampin

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; RIFAMPICIN;

ACUTE KIDNEY FAILURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GROUP TYPING; BREATHING RATE; CLINICAL FEATURE; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PROGNOSIS; RATING SCALE; RETROSPECTIVE STUDY; SEROCONVERSION; SMOKING; THORAX RADIOGRAPHY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; CREATINE KINASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SPAIN;

EID: 0142027079     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13051902     Document Type: Article

References (28)

1. Fraser DW, Tsai TR, Orenstein W, Parkin WE, Beecham HJ, Sharrar RG, et al. Legionnaires' disease: Description of an epidemic of pneumonia. N Engl J Med 1977;297:1189-97.
2. Vergis EN, Indorf A, File TM Jr, Philips J, Bates J, Tan J, et al. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: A prospective, randomized, multicenter trial. Arch intern Med 2000;160:1294-300.
3. Yu VL, Plouffe JF, Pastoris MC, Stout JE, Schousboe M, Widmer A, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: An international collaborative survey. J Infect Dis 2002;186:127-8.
4. Ansola P, Sobradillo V, Baranda F, Gaztelurrutia L, Llorente JL, Antoñana JM. Neumonía adquiridas en la comunidad de Vizcaya. Arch Bronconeumol 1990;263:103-7.
5. Zalacain R, Llorente JL, Gaztelurrutia L, Zenarruzabeitia E, Uresandi F, Sobradillo V. La punción transtorácica aspirativa con aguja ultrafina en las neumonías de alto riesgo adquiridas en la comunidad. Med Clin (Barc) 1993; 100:567-70.
6. Ausina V, Coll P, Sambeat M, Puig I, Condom MJ, Luquin M, et al. Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain. Eur J Clin Microbiol Infect Dis 1988;7:343-7.
7. Blanquer J, Blanquer R, Borrás R, Nauffal D, Morales P, Menéndez R, et al. Aetiology of community-acquired pneumonia in Valencia, Spain: A multicentre propective study. Thorax 1991;46:508-11.
8. Ruiz M, Ewig S, Marcos MA, Martínez JA, Arancibia F, Mensa J, et al. Etiology of community-acquired pneumonia: Impact of age, comorbidity and severity. Am J Respir Crit Care Med 1999;160:397-405.
9. Rosón B, Carratalá J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001;33:158-65.
10. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
11. Carmona G, Cardeñosa N, Domínguez A. Epidemiología descriptiva de la legionelosis. Cataluña 1997-2000. Med Clin (Barc) 2002;119(Supl 2):25-8.
12. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Involvement of nicotinic acetylcholine receptors in supression of antimicrobiol activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001;167:6518-24.
13. Sopena N, Sabría-Leal M, Pedro-Botat ML, Padilla E, Domínguez J, Morera J, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 1998;113:1195-200.
14. Fernández JA, López P, Orozco D, Merino J. Clinical study of the outbreak af Legionnaire's disease in Alcoy, Southeastern Spain. Eur J Clin Microbiol Infect Dis 2002;21:729-35.
15. Lieberman D, Porath A, Schlaeffer F, Lieberman D, Boldur I. Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest 1996;109:1243-9.
16. Grau JM. Miositis y rabdomiólisis en el contexto de enfermedades infecciosas. Delimitaciones conceptuales y actitudes clínicas. Enferm Infecc Microbiol Clin 1994;12:49-51.
17. Gutiérrez A, Arriaga I, Varona M. Rabdomiólisis asociada a neumonía por Legionella pneumophila. Enferm Infecc Microbiol Clin 1997;12:43-4.
18. Blazquez JC, Quiles I, De Teresa L. Rabdomiólisis asociada a neumonía por Streptococcus pneumoniae y Legionella pneumophila. Enferm Infecc Microbiol Clin 2000;18:52-3.
19. Arrizabalaga P, Montoliu J, Parés A, Nogué S, Bravo H, Darnell A, et al. Rabdomiólisis e insuficiencia renal aguda en la enfermedad del legionario. Med Clin (Barc) 1984;82:209-13.
20. Supervia A, Peña MJ, Galofre N, Knobel H. Rabdomiólisis e insuficiencia renal aguda en un paciente con enfermedad del legionario. An Med Inter 1994; 11:102-3.
21. Shah A, Check F, Baskin S, Reyman T, Menard R. Legionnaire's Disease and Acute renal Failure: Case report and review. Clin Infect Dis 1992;14:204-7.
22. Plouffe JF, File TM Jr, Breiman RF, Hackman BA, Salstrom SJ, Marston BJ, et al. Reevaluation of the definition of Legionnaires' disease: Use of the urinary antigen assay. Community based pneumonia incidence study group. Clin Infect Dis 1995;20:1286-91.
23. Mcwhinney PH, Ragunathan PL, Rowbottam TS. Failure to produce detectable antibodies to Legionella pneumophila by immunocompetent adult. J Infect 2000;41:91-2.
24. Waterer GW, Baselski VS, Wunderink RG. Legionella and community-acquired pneumonia: A review of current diagnostic tests from a clinician's viewpoint. Am J Med 2001;110:41-8.
25. Dedicoat M, Venkatesan P. The treatment of Legionnaires' disease. J Antimicrob Chemother 1999;43:747-52.
26. Stout JE, Yu VL. Legionellosis. N Engl J Med 1997;337:682-7.
27. Gómez-Lus R, Adrián F, Del Campo R, Gómez-Lus P, Sánchez S, García C, et al. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. Int J Antimicrob Agents 2001;18:49-54.
28. Benin AL, Benson RF, Besser RE. Trends in Legionnaires diseasse, 1980-1998: Declining mortality and new patterns of diagnosis. Clin Infect Dis 2002;35:1039-46.